Senior Director, Corporate Affairs, Communications and Public Advocacy, Italy
Pubblicato il 16-08-2026 - Revolution Medicines in Italia
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D; pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Candidarsi per questo ruolo è facile. Scorra verso il basso e faccia clic su "Candidati" per essere preso/a in considerazione per questa posizione.
The Opportunity
The Senior Director, Corporate Affairs,
Communication and Policy Advocacy will lead the development and execution of oncology-focused Corporate Affairs strategies in Italy that support the company’s mission of revolutionizing treatment for patients with RAS-addicted cancers. These Corporate Affairs strategies bring together media relations, corporate public affairs, product communications, corporate reputation management and internal communications.
Key Responsibilities
Media Relations
-
- Acts as spokesperson in Italy, directing enquiries to internal experts as needed.
- Drives proactive media content and strategy around trial results, regulatory milestones, and major oncology congresses (ASCO, ESMO).
- Builds and maintains trusted relationships with top-tiers in Italy and trade media, ensuring accurate representation of company positions and achievements.
- Monitors media coverage and sentiment, flagging emerging narratives before they require a crisis response.
- Ensures consistent messaging across earned, owned, and shared channels, and aligns spokesp